The hormonal treatment with low doses of FSH and LH has been found effective in PCOS patients by reducing the incidence of ovarian hyperstimulation, which is considered one of the significant risk factors in PCOS [165]. The gene discussed is BRD2; the disease is polycystic ovary syndrome.